ULBP1 and ductal breast carcinoma in situ: The increased sULBP1 and sULBP3 levels in DCIS patients compared to healthy volunteers may indicate possible overexpression of ULBP1 and ULPB3 already on DCIS tissue and thus ligand cleavage as an early mechanism of immune evasion.